Abstract
In October 2018, prior to the legalization of cannabis in Canada, a survey was completed by 1050 Memorial University of Newfoundland students. Both descriptive quantitative and thematic qualitative data analyzes were used. Approximately 16% of the sample reported ever using cannabis for medicinal purposes (n=175), with only 16.6% of medicinal users reporting authorization by a healthcare provider (HCP). The majority (80.2%) were aware of possible side effects of cannabis. Prior personal experience (65.3%) and peer influence (59.5%) informed participants’ medicinal use. Approximately 40% reported having replaced/reduced prescribed medication. Roughly 60% of medicinal users had not disclosed their use to their HCP. Consistent with previous studies, medicinal cannabis use among postsecondary students appears to be largely motivated for mental health related conditions and is grounded in personal experience versus evidence-based guidelines. There is a need for increased communication between HCPs and patients to promote lower-risk use among medicinal cannabis users.
Similar content being viewed by others
References
Fischer B, Kuganesan S, Room R. Medical marijuana programs: Implications for cannabis control policy – observations from Canada. International Journal on Drug Policy. 2015;26(1):15-19. https://doi.org/10.1016/j.drugpo.2014.09.007
Health Canada. Data on Cannabis for Medical Purposes. Available online at https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/medical-purpose.html. Accessed on April 22, 2020.
Volkow ND, Baler RD, Compton WM, et al. Adverse health effects of marijuana use. The New England Journal of Medicine. 2014;370(23):2219-2227. https://doi.org/10.1056/NEJMra1402309
Statistics Canada. National Cannabis Survey, Second Quarter 2019. Available online at https://www150.statcan.gc.ca/n1/daily-quotidien/190815/dq190815a-eng.htm. Accessed April 21, 2020.
American College Health Association [ACHA]. American College Health Association – National College Health Assessment II: Canadian Reference Group, Executive Summary Spring 2019. Silver Spring, MD: ACHA, 2019.
King N, Pickett W, McNevin SH, et al. Mental health need of students at entry to university: Baseline findings from the U-Flourish student well-being and academic success study. Early Intervention in Psychiatry. 2020;15(2):286-295. https://doi.org/10.1111/eip.12939
National Academies of Sciences, Engineering and Medicine. The Health Effects of Cannabis and Cannabinoids: Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press, 2017.
Di Forti M, Quattrone D, Freeman TP, et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): A multicentre case-control study. Lancet Psychiatry. 2019;6(5):427-436. https://doi.org/10.1016/S2215-0366(19)30048-3
Arria AM, Caldeira KM, Bugbee BA, et al. The academic consequences of marijuana use during college. Psychology of Addictive Behaviors. 2015;29(3):564-575. https://doi.org/10.1037/adb0000108
Suerken CK, Reboussin BA, Egan KL, et al. Marijuana use trajectories and academic outcomes among college students. Drug and Alcohol Dependence. 2016;162:137-145. https://doi.org/10.1016/j.drugalcdep.2016.02.041
Cuttler C, Spradlin A, McLaughlin RJ. A naturalistic examination of the perceived effects of cannabis on negative affect. Journal of Affective Disorders. 2018;235:198-205. https://doi.org/10.1016/j.jad.2018.04.054
Gobbi G, Atkin T, Zytynski T, et al. Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: A systematic review and meta-analysis. JAMA Psychiatry. 2019;76(4):426. https://doi.org/10.1001/jamapsychiatry.2018.4500
Schoeler T, Theobald D, Pingault J-B, et al. Developmental sensitivity to cannabis use patterns and risk for major depressive disorder in mid-life: Findings from 40 years of follow-up. Psychological Medicine. 2018;48(13):2169-2176. https://doi.org/10.1017/S0033291717003658
Cougle JR, Hakes JK, Macatee RJ, et al. Quality of life and risk of psychiatric disorders among regular users of alcohol, nicotine, and cannabis: An analysis of the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). Journal of Psychiatric Research. 2015;66-67:135-141. https://doi.org/10.1016/j.jpsychires.2015.05.004
Danielsson A-K, Lundin A, Agardh E, et al. Cannabis use, depression and anxiety: A 3-year prospective population-based study. Journal of Affective Disorders. 2016;193:103-108. https://doi.org/10.1016/j.jad.2015.12.045
Feingold D, Weiser M, Rehm J, et al. The association between cannabis use and anxiety disorders: Results from a population-based representative sample. European Neuropsychopharmacology. 2016;26(3):493-505. https://doi.org/10.1016/j.euroneuro.2015.12.037
Mader J, Smith JM, Afzal AR, et al. Correlates of lifetime cannabis use and cannabis use severity in a Canadian university sample. Addictive Behaviors. 2019;98:106015. https://doi.org/10.1016/j.addbeh.2019.06.004
Han B, Compton WM, Blanco C, et al. Trends in and correlates of medical marijuana use among adults in the United States. Drug and Alcohol Dependence. 2018;186:120-129. https://doi.org/10.1016/j.drugalcdep.2018.01.022
Cavazos-Rehg PA, Krauss MJ, Cahn E, et al. Marijuana promotion online: An investigation of dispensary practices. Prevention Science. 2019;20(2):280-290. https://doi.org/10.1007/s11121-018-0889-2
Lankenau SE, Ataiants J, Mohanty S, et al. Health conditions and motivations for marijuana use among young adult medical marijuana patients and non-patient marijuana users: Health conditions and motivations. Drug and Alcohol Review. 2018;37(2):237-246. https://doi.org/10.1111/dar.12534
Smith JM, Mader J, Szeto ACH, et al. Cannabis use for medicinal purposes among Canadian university students. The Canadian Journal of Psychiatry. 2019;64(5):351-355. https://doi.org/10.1177/0706743718818420
Sexton M, Cuttler C, Finnell JS, et al. A cross-sectional survey of medical cannabis users: Patterns of use and perceived efficacy. Cannabis and Cannabinoid Research. 2016;1(1):131-138. https://doi.org/10.1089/can.2016.0007
Sarris J, Sinclair J, Karamacoska D, et al. Medicinal cannabis for psychiatric disorders: A clinically-focused systematic review. BMC Psychiatry. 2020;20(1):24. https://doi.org/10.1186/s12888-019-2409-8
Mercurio A, Aston ER, Claborn KR, et al. Marijuana as a substitute for prescription medications: A qualitative study. Substance Use & Misuse. 2019;54(11):1894-1902. https://doi.org/10.1080/10826084.2019.1618336
Reiman A, Welty M, Solomon P. Cannabis as a substitute for opioid-based pain medication: Patient self-report. Cannabis and Cannabinoid Research. 2017;2(1):160-166. https://doi.org/10.1089/can.2017.0012
Health Canada. Canadian Cannabis Survey 2018 Summary. Available online at https://www.canada.ca/en/services/health/publications/drugs-health-products/canadian-cannabis-survey-2018-summary.html. Accessed on April 22, 2020.
College of Physicians and Surgeons of British Columbia [CPSBC]. Practice Standard: Cannabis for Medical Purposes. Available online at https://www.cpsbc.ca/files/pdf/PSG-Cannabis-for-Medical-Purposes.pdf. Accessed May 6, 2020.
Health Canada. Consumer Information - Cannabis (Marihuana, Marijuana). Available online at https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/licensed-producers/consumer-information-cannabis.html. Accessed April 23, 2020.
Mental Health Commission of Canada [MHCC]. Cannabis and Mental Health: Priorities for Research in Canada. Available online at https://www.mentalhealthcommission.ca/sites/default/files/2019-07/Cannabis_mental_Health_Summary_july_2019_eng.pdf. Accessed May 6, 2020.
Dillman DA, Smyth JD, Christian LM. Internet, Phone, Mail, and Mixed-Mode Surveys: The Tailored Design Method, 4th edition. Hoboken, NJ: Wiley, 2014.
Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006;3(2):77-101. https://doi.org/10.1191/1478088706qp063oa
Adamson SJ, Kay-Lambkin FJ, Baker AL, et al. An improved brief measure of cannabis misuse: The Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug and Alcohol Dependence. 2010;110(1-2):137-143. https://doi.org/10.1016/j.drugalcdep.2010.02.017
Schultz NR, Bassett DT, Messina BG, et al. Evaluation of the psychometric properties of the Cannabis Use Disorders Identification Test - Revised among college students. Addictive Behaviors. 2019;95:11-15. https://doi.org/10.1016/j.addbeh.2019.02.016
Memorial University of Newfoundland [MUN]. Memorial University of Newfoundland Annual Report 2018-19. Available online at https://www.mun.ca/hr/services/benefits/MemorialUniversityReport2018-19R.pdf. Accessed May 5, 2020.
Lankenau SE, Kioumarsi A, Reed M, et al. Becoming a medical marijuana user. International Journal of Drug Policy. 2018;52:62-70. https://doi.org/10.1016/j.drugpo.2017.11.018
Bostwick JM. Blurred boundaries: The therapeutics and politics of medical marijuana. Mayo Clinic Proceedings. 2012;87(2):172-186. https://doi.org/10.1016/j.mayocp.2011.10.003
Gertsch J. The intricate influence of the placebo effect on medical cannabis and cannabinoids. Medical Cannabis and Cannabinoids. 2018;1(1):60-64. https://doi.org/10.1159/000489291
Charlebois S, Music J, Sterling B, et al. Edibles and Canadian consumers’ willingness to consider recreational cannabis in food or beverage products: A second assessment. Trends in Food Science & Technology. 2020;98:25-29. https://doi.org/10.1016/j.tifs.2019.12.025
Health Canada. Canadian Cannabis Survey 2019 - Summary. Available online at https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/canadian-cannabis-survey-2019-summary.html. Accessed April 22, 2020.
Gardiner KM, Singleton JA, Sheridan J, et al. Health professional beliefs, knowledge, and concerns surrounding medicinal cannabis – A systematic review. PLOS ONE. 2019;14(5):e0216556. https://doi.org/10.1371/journal.pone.0216556
Canadian Medical Protective Association [CMPA]. Medical Cannabis: Considerations for Canadian Doctors. Available online at https://www.cmpa-acpm.ca/en/advice-publications/browse-articles/2014/medical-marijuana-new-regulations-new-college-guidance-for-canadian-doctors. Accessed April 21, 2020.
Leos-Toro C, Shiplo S, Hammond D. Perceived support for medical cannabis use among approved medical cannabis users in Canada. Drug and Alcohol Review. 2018;37(5):627-636. https://doi.org/10.1111/dar.12823
Hasin DS, Saha TD, Kerridge BT, et al. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry. 2015;72(12):1235. https://doi.org/10.1001/jamapsychiatry.2015.1858
College of Physicians and Surgeons of Newfoundland [CPSNL]. Medical Marihuana: Advisory and Interim Guideline. Available online at https://www.cpsnl.ca/WEB/CPSNL/Policies/Advisory_and_Interim_Guideline_-_Medical_Marihuana.aspx. Accessed April 21, 2020.
Acknowledgements
We would like to acknowledge Dr. Elizabeth Cawley and Dr. Andrew Szeto for their support in this project.
Ethics Approval
The study was approved by MUNs Interdisciplinary Committee on Ethics in Human Research (ICEHR No. 20190765-EX) and the University of Calgary’s Conjoint Health Research Ethics Board (REB18-0184).
Author information
Authors and Affiliations
Contributions
Dr. JS, Dr. JM & JM designed the study. JS, JM, GG, LC completed quantitative and qualitative data analysis. All authors contributed to and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest. This research was funded by the Faculty of Nursing, University of Calgary and the Faculty of Nursing, Memorial University of Newfoundland.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Smith, J., Smith, J., Mader, J. et al. An Exploration of Self-Reported Medicinal Cannabis Use Among a Sample of Eastern Canadian Postsecondary Students. J Behav Health Serv Res 49, 487–499 (2022). https://doi.org/10.1007/s11414-021-09763-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11414-021-09763-3